Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 54 Neoplasms 3 Radiation Injuries 2 Uterine Cervical Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer With Intermediate Risk 1 Melanoma 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Directly Observed Therapy 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 6 Cyclophosphamide 6 fludarabine phosphate 5 Nivolumab 5 Mycophenolic Acid 5 Carboplatin 5 Whole-Body Irradiation 4 Radiotherapy 4 Filgrastim 4 Cyclosporine 4 Gemcitabine 3 Cisplatin 3 Busulfan 3 Antilymphocyte Serum 3 cabozantinib 2 cabazitaxel 2 Voriconazole 2 Thiotepa 2 Therapeutics 2 Standard of Care 2 Sirolimus 2 Polymerase Chain Reaction 2 Mitomycin 2 Methylprednisolone 2 Methotrexate 2 Melphalan 2 Itraconazole 2 Immunoglobulin G 2 Goserelin 2 Flow Cytometry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Brachytherapy × Genitourinary × Clear all

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡